Correction to: Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor
In the original publication of this article, the license subtype should be CC BY and not CC BY-NC.
Gespeichert in:
| Veröffentlicht in: | Investigational new drugs 2019-06, Vol.37 (3), p.591-591 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 591 |
|---|---|
| container_issue | 3 |
| container_start_page | 591 |
| container_title | Investigational new drugs |
| container_volume | 37 |
| creator | Ito, Tetsuhide Okusaka, Takuji Nishida, Toshirou Yamao, Kenji Igarashi, Hisato Morizane, Chigusa Kondo, Shunsuke Mizuno, Nobumasa Hara, Kazuo Sawaki, Akira Hashigaki, Satoshi Kimura, Nobuyuki Murakami, Mami Ohki, Emiko Chao, Richard C. Imamura, Masayuki |
| description | In the original publication of this article, the license subtype should be CC BY and not CC BY-NC. |
| doi_str_mv | 10.1007/s10637-019-00757-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6828105</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2196527425</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2709-a85e6b862ae39169f20329eaad27760b930ccc25c277a372387f2c22ff1902e53</originalsourceid><addsrcrecordid>eNp9kctu1DAUhi0EokPhBVggS2xYEPAlsWMWldCIy6BKsIC15TgnHVeJPfhC1ffggXGYUi4LVpZ9vv8_5_hH6DElLygh8mWiRHDZEKqaeu1ko-6gDe0kb4hoxV20IVTIRiglT9CDlC4JIVzJ9j464UQRztt2g75vQ4xgswse5_AKf9qbBHi3wymX8RqHCafiXXbeDdh5_MEcjIdKHEx24HPCVy7vcfGxPtpshhlwiHiBbFKuiH2Or2Cem9FNE8QqcCbDWNXeRljr2EOJAfwYbHQecC5LiA_RvcnMCR7dnKfoy9s3n7fvm_OP73bb1-eNZZKoxvQdiKEXzABXVKiJEc4UGDMyKQUZFCfWWtZVWhouGe_lxCxj00QVYdDxU3R29D2UYYHR1vmimfUhusXEax2M039XvNvri_BNi571lKwGz24MYvhaIGW9uGTrwvWTQkmaUSU6Jlu2ok__QS9Dib6ut1I1tK4mWCl2pGwMKUWYboehRK-h62Pouoauf4auVRU9-XONW8mvlCvAj0CqJX8B8Xfv_9j-AHMMuwQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2195735757</pqid></control><display><type>article</type><title>Correction to: Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor</title><source>Springer journals</source><creator>Ito, Tetsuhide ; Okusaka, Takuji ; Nishida, Toshirou ; Yamao, Kenji ; Igarashi, Hisato ; Morizane, Chigusa ; Kondo, Shunsuke ; Mizuno, Nobumasa ; Hara, Kazuo ; Sawaki, Akira ; Hashigaki, Satoshi ; Kimura, Nobuyuki ; Murakami, Mami ; Ohki, Emiko ; Chao, Richard C. ; Imamura, Masayuki</creator><creatorcontrib>Ito, Tetsuhide ; Okusaka, Takuji ; Nishida, Toshirou ; Yamao, Kenji ; Igarashi, Hisato ; Morizane, Chigusa ; Kondo, Shunsuke ; Mizuno, Nobumasa ; Hara, Kazuo ; Sawaki, Akira ; Hashigaki, Satoshi ; Kimura, Nobuyuki ; Murakami, Mami ; Ohki, Emiko ; Chao, Richard C. ; Imamura, Masayuki</creatorcontrib><description>In the original publication of this article, the license subtype should be CC BY and not CC BY-NC.</description><identifier>ISSN: 0167-6997</identifier><identifier>EISSN: 1573-0646</identifier><identifier>DOI: 10.1007/s10637-019-00757-9</identifier><identifier>PMID: 30903344</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Correction ; Medicine ; Medicine & Public Health ; Metastases ; Neuroendocrine tumors ; Oncology ; Pancreas ; Pharmacology/Toxicology</subject><ispartof>Investigational new drugs, 2019-06, Vol.37 (3), p.591-591</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2019</rights><rights>Investigational New Drugs is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10637-019-00757-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10637-019-00757-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30903344$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ito, Tetsuhide</creatorcontrib><creatorcontrib>Okusaka, Takuji</creatorcontrib><creatorcontrib>Nishida, Toshirou</creatorcontrib><creatorcontrib>Yamao, Kenji</creatorcontrib><creatorcontrib>Igarashi, Hisato</creatorcontrib><creatorcontrib>Morizane, Chigusa</creatorcontrib><creatorcontrib>Kondo, Shunsuke</creatorcontrib><creatorcontrib>Mizuno, Nobumasa</creatorcontrib><creatorcontrib>Hara, Kazuo</creatorcontrib><creatorcontrib>Sawaki, Akira</creatorcontrib><creatorcontrib>Hashigaki, Satoshi</creatorcontrib><creatorcontrib>Kimura, Nobuyuki</creatorcontrib><creatorcontrib>Murakami, Mami</creatorcontrib><creatorcontrib>Ohki, Emiko</creatorcontrib><creatorcontrib>Chao, Richard C.</creatorcontrib><creatorcontrib>Imamura, Masayuki</creatorcontrib><title>Correction to: Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor</title><title>Investigational new drugs</title><addtitle>Invest New Drugs</addtitle><addtitle>Invest New Drugs</addtitle><description>In the original publication of this article, the license subtype should be CC BY and not CC BY-NC.</description><subject>Correction</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metastases</subject><subject>Neuroendocrine tumors</subject><subject>Oncology</subject><subject>Pancreas</subject><subject>Pharmacology/Toxicology</subject><issn>0167-6997</issn><issn>1573-0646</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp9kctu1DAUhi0EokPhBVggS2xYEPAlsWMWldCIy6BKsIC15TgnHVeJPfhC1ffggXGYUi4LVpZ9vv8_5_hH6DElLygh8mWiRHDZEKqaeu1ko-6gDe0kb4hoxV20IVTIRiglT9CDlC4JIVzJ9j464UQRztt2g75vQ4xgswse5_AKf9qbBHi3wymX8RqHCafiXXbeDdh5_MEcjIdKHEx24HPCVy7vcfGxPtpshhlwiHiBbFKuiH2Or2Cem9FNE8QqcCbDWNXeRljr2EOJAfwYbHQecC5LiA_RvcnMCR7dnKfoy9s3n7fvm_OP73bb1-eNZZKoxvQdiKEXzABXVKiJEc4UGDMyKQUZFCfWWtZVWhouGe_lxCxj00QVYdDxU3R29D2UYYHR1vmimfUhusXEax2M039XvNvri_BNi571lKwGz24MYvhaIGW9uGTrwvWTQkmaUSU6Jlu2ok__QS9Dib6ut1I1tK4mWCl2pGwMKUWYboehRK-h62Pouoauf4auVRU9-XONW8mvlCvAj0CqJX8B8Xfv_9j-AHMMuwQ</recordid><startdate>201906</startdate><enddate>201906</enddate><creator>Ito, Tetsuhide</creator><creator>Okusaka, Takuji</creator><creator>Nishida, Toshirou</creator><creator>Yamao, Kenji</creator><creator>Igarashi, Hisato</creator><creator>Morizane, Chigusa</creator><creator>Kondo, Shunsuke</creator><creator>Mizuno, Nobumasa</creator><creator>Hara, Kazuo</creator><creator>Sawaki, Akira</creator><creator>Hashigaki, Satoshi</creator><creator>Kimura, Nobuyuki</creator><creator>Murakami, Mami</creator><creator>Ohki, Emiko</creator><creator>Chao, Richard C.</creator><creator>Imamura, Masayuki</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>K60</scope><scope>K6~</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>L.-</scope><scope>M0C</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201906</creationdate><title>Correction to: Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor</title><author>Ito, Tetsuhide ; Okusaka, Takuji ; Nishida, Toshirou ; Yamao, Kenji ; Igarashi, Hisato ; Morizane, Chigusa ; Kondo, Shunsuke ; Mizuno, Nobumasa ; Hara, Kazuo ; Sawaki, Akira ; Hashigaki, Satoshi ; Kimura, Nobuyuki ; Murakami, Mami ; Ohki, Emiko ; Chao, Richard C. ; Imamura, Masayuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2709-a85e6b862ae39169f20329eaad27760b930ccc25c277a372387f2c22ff1902e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Correction</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metastases</topic><topic>Neuroendocrine tumors</topic><topic>Oncology</topic><topic>Pancreas</topic><topic>Pharmacology/Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ito, Tetsuhide</creatorcontrib><creatorcontrib>Okusaka, Takuji</creatorcontrib><creatorcontrib>Nishida, Toshirou</creatorcontrib><creatorcontrib>Yamao, Kenji</creatorcontrib><creatorcontrib>Igarashi, Hisato</creatorcontrib><creatorcontrib>Morizane, Chigusa</creatorcontrib><creatorcontrib>Kondo, Shunsuke</creatorcontrib><creatorcontrib>Mizuno, Nobumasa</creatorcontrib><creatorcontrib>Hara, Kazuo</creatorcontrib><creatorcontrib>Sawaki, Akira</creatorcontrib><creatorcontrib>Hashigaki, Satoshi</creatorcontrib><creatorcontrib>Kimura, Nobuyuki</creatorcontrib><creatorcontrib>Murakami, Mami</creatorcontrib><creatorcontrib>Ohki, Emiko</creatorcontrib><creatorcontrib>Chao, Richard C.</creatorcontrib><creatorcontrib>Imamura, Masayuki</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing & Allied Health Database</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Global (ProQuest)</collection><collection>ProQuest Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>One Business (ProQuest)</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Investigational new drugs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ito, Tetsuhide</au><au>Okusaka, Takuji</au><au>Nishida, Toshirou</au><au>Yamao, Kenji</au><au>Igarashi, Hisato</au><au>Morizane, Chigusa</au><au>Kondo, Shunsuke</au><au>Mizuno, Nobumasa</au><au>Hara, Kazuo</au><au>Sawaki, Akira</au><au>Hashigaki, Satoshi</au><au>Kimura, Nobuyuki</au><au>Murakami, Mami</au><au>Ohki, Emiko</au><au>Chao, Richard C.</au><au>Imamura, Masayuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correction to: Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor</atitle><jtitle>Investigational new drugs</jtitle><stitle>Invest New Drugs</stitle><addtitle>Invest New Drugs</addtitle><date>2019-06</date><risdate>2019</risdate><volume>37</volume><issue>3</issue><spage>591</spage><epage>591</epage><pages>591-591</pages><issn>0167-6997</issn><eissn>1573-0646</eissn><abstract>In the original publication of this article, the license subtype should be CC BY and not CC BY-NC.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>30903344</pmid><doi>10.1007/s10637-019-00757-9</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0167-6997 |
| ispartof | Investigational new drugs, 2019-06, Vol.37 (3), p.591-591 |
| issn | 0167-6997 1573-0646 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6828105 |
| source | Springer journals |
| subjects | Correction Medicine Medicine & Public Health Metastases Neuroendocrine tumors Oncology Pancreas Pharmacology/Toxicology |
| title | Correction to: Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T14%3A31%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correction%20to:%20Phase%20II%20study%20of%20sunitinib%20in%20Japanese%20patients%20with%20unresectable%20or%20metastatic,%20well-differentiated%20pancreatic%20neuroendocrine%20tumor&rft.jtitle=Investigational%20new%20drugs&rft.au=Ito,%20Tetsuhide&rft.date=2019-06&rft.volume=37&rft.issue=3&rft.spage=591&rft.epage=591&rft.pages=591-591&rft.issn=0167-6997&rft.eissn=1573-0646&rft_id=info:doi/10.1007/s10637-019-00757-9&rft_dat=%3Cproquest_pubme%3E2196527425%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2195735757&rft_id=info:pmid/30903344&rfr_iscdi=true |